一代与二代酪氨酸激酶抑制剂联合化疗序贯异基因造血干细胞移植治疗Ph(+)急性淋巴细胞白血病疗效比较

OBJECTIVE: To investigate the efficacy of sequential treatment with first-line administration of second-generation tyrosine kinase inhibitors (TKI) and first-generation TKI (imatinib) in patients with Ph(+) acute lymphoblastic leukemia (Ph(+) ALL) followed by allogeneic hematopoietic stem cell trans...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2018
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342571/
https://www.ncbi.nlm.nih.gov/pubmed/29562444
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342571/
https://www.ncbi.nlm.nih.gov/pubmed/29562444
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.02.007

Ejemplares similares